Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 114.04 CHF 0.25% Market Closed
Market Cap: 218.8B CHF

Intrinsic Value

The intrinsic value of one NOVN stock under the Base Case scenario is 118.68 CHF. Compared to the current market price of 114.04 CHF, Novartis AG is Undervalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NOVN Intrinsic Value
118.68 CHF
Undervaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Novartis AG

What is Valuation History?
Ask AI Assistant
What other research platforms think about NOVN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NOVN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Novartis AG.

Explain Valuation
Compare NOVN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NOVN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novartis AG

Current Assets 28.2B
Cash & Short-Term Investments 9.7B
Receivables 9B
Other Current Assets 9.5B
Non-Current Assets 79.1B
Long-Term Investments 2.2B
PP&E 12B
Intangibles 54.6B
Other Non-Current Assets 10.4B
Current Liabilities 32B
Accounts Payable 4.6B
Other Current Liabilities 27.4B
Non-Current Liabilities 31B
Long-Term Debt 24.2B
Other Non-Current Liabilities 6.7B
Efficiency

Free Cash Flow Analysis
Novartis AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Novartis AG

Revenue
56B USD
Cost of Revenue
-13.4B USD
Gross Profit
42.6B USD
Operating Expenses
-24.1B USD
Operating Income
18.6B USD
Other Expenses
-4.2B USD
Net Income
14.4B USD
Fundamental Scores

NOVN Profitability Score
Profitability Due Diligence

Novartis AG's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Exceptional Operating Margin
67/100
Profitability
Score

Novartis AG's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

NOVN Solvency Score
Solvency Due Diligence

Novartis AG's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
66/100
Solvency
Score

Novartis AG's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NOVN Price Targets Summary
Novartis AG

Wall Street analysts forecast NOVN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOVN is 110.13 CHF with a low forecast of 88.88 CHF and a high forecast of 133.14 CHF.

Lowest
Price Target
88.88 CHF
22% Downside
Average
Price Target
110.13 CHF
3% Downside
Highest
Price Target
133.14 CHF
17% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NOVN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

NOVN News

Other Videos
What is the Intrinsic Value of one NOVN stock?

The intrinsic value of one NOVN stock under the Base Case scenario is 118.68 CHF.

Is NOVN stock undervalued or overvalued?

Compared to the current market price of 114.04 CHF, Novartis AG is Undervalued by 4%.

Back to Top